Connor, Clark & Lunn Investment Management (CC&L)’s BioTelemetry, Inc. BEAT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-25,900	Closed	-$244K	–	845
2015 Q2	$244K	Sell	25,900 -4,400	-15%	-$40.7K	﹤0.01%	524
2015 Q1	$268K	Sell	30,300 -10,000	-25%	-$101K	﹤0.01%	469
2014 Q4	$404K	Buy	40,300 +21,200	+111%	+$182K	﹤0.01%	421
2014 Q3	$128K	Buy	+19,100	New	+$134K	﹤0.01%	514
2014 Q2	–	Sell	-54,400	Closed	-$606K	–	733
2014 Q1	$606K	Buy	54,400 +22,600	+71%	+$208K	﹤0.01%	455
2013 Q4	$268K	Buy	+31,800	New	+$297K	﹤0.01%	621

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BEAT Position: Q3 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BioTelemetry, Inc. (BEAT) in Q3 2015, closing a stake of 25,900 shares — an estimated $244K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BEAT in Q4 2013 and held it in 6 quarters. The position peaked at $606K in Q1 2014. 119 funds tracked by Wall St. Rank hold BEAT as of Q3 2015.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BioTelemetry, Inc. position as of Q3 2015 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 25,900 BioTelemetry, Inc. shares in Q3 2015, an estimated $244K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s BioTelemetry, Inc. position peaked at $606K in Q1 2014.
119 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2015, filed 13 Nov 2015.